Sparkling Sciences

What Sparkling Sciences does

Sparkling Sciences Co., Ltd. (氣泡科技股份有限公司) is a Taiwan-based biotechnology company founded in 2024 as the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). The company specializes in exosome and extracellular vesicle (EV) technology, offering high-purity extraction and mass production of exosomes derived from multiple animal cell sources — Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) — as well as from plant cells. Its core technical platform combines proprietary lyophilization (freeze-drying) technology operating at -40°C to -80°C, which preserves exosome bioactivity without thermal degradation and enables room-temperature shelf stability, reducing cold-chain dependency for global distribution.

The company operates a B2B ingredients-and-services model targeting cosmetics and skincare brands, pet health companies, and research institutions. Revenue is generated through (1) supply of exosome and plant EV raw materials in lyophilized powder and frozen liquid formats, (2) OEM/ODM contract manufacturing for cosmetics and skincare brands, and (3) fee-for-service lyophilization processing for third-party exosomes, proteins, and natural extracts. Two ingredients have obtained INCI (International Nomenclature of Cosmetic Ingredients) registration — Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956) — with an iPSC Exosome INCI registration announced in mid-2026. The company has also launched four consumer-facing sub-brands (Karela, MUiKA, J-STARMi, iLISSE) and established a Tokyo subsidiary, ArcBio Co., Ltd., in 2025 to support Japan market entry.

Name

Sparkling Sciences

Legal name

氣泡科技股份有限公司

Website

https://sparklingsci.com

Company type

Private

Founded year

2024

Operating status

Operating

Short description

Sparkling Sciences is a Taiwan-based biotechnology company founded in 2024 that extracts, mass-produces, and lyophilizes exosomes from animal and plant cells, supplying INCI-registered raw materials, OEM/ODM services, and consumer sub-brands to cosmetics, skincare, and pet health clients across Asia-Pacific.

Ownership category

akta.pro rank

Product category

Biotechnology Ingredients and OEM Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Personal Care & Cosmetic Ingredients (IMAEABAJ)

Keywords

• Exosome raw materials
• Plant extracellular vesicles
• Cosmetic OEM manufacturing
• Lyophilization services
• Pet biotech ingredients

Headquarters

HQ city

Taichung City

HQ country

Taiwan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D

Revenue model

1. Exosome and Cell Raw Materials Supply: Supply of high-purity exosome raw materials (animal and plant-derived) to cosmetics and skincare brands, pet health companies, and research institutions. Offered in lyophilized powder (long-term stable) and frozen liquid (high activity) formats, with customization options for cell source, concentration, and packaging.
2. OEM/ODM Contract Manufacturing: One-stop OEM/ODM services for cosmetics and skincare brands, from concept design to finished product manufacturing, leveraging exosome-based and plant EV-based ingredient formulations. Supports brand partners in developing differentiated skincare, haircare, and pet wellness products.
3. Lyophilization (Freeze-Drying) Service: Fee-for-service lyophilization processing for third-party exosomes, proteins, natural plant extracts, and cytokines, serving research institutions, biotech companies, and cosmetics manufacturers needing preserved bioactive samples.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Sparkling Sciences is a Taiwan-based biotechnology company that extracts, mass-produces, and supplies exosome and plant extracellular vesicle (EV) raw materials derived from animal cells (MSC, iPSC, Fibroblast, NSC, HPC) and functional plant sources. The company sells INCI-registered cosmetic ingredients, provides pet exosome customization, and offers end-to-end OEM/ODM contract manufacturing for skincare and haircare brands, supported by proprietary lyophilization (freeze-drying) technology for shelf-stable bioactive products.

Product overview

Sparkling Sciences (氣泡科技股份有限公司) operates as a biotechnology company specializing in exosome technology research, development, and manufacturing. The company offers a comprehensive portfolio comprising: (1) Stem cell products including Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) for pet applications; (2) Exosome extraction and mass production services for both animal-derived and plant-derived extracellular vesicles; (3) Professional lyophilization (freeze-drying) services for preserving bioactive molecules; (4) Cosmetic/skincare raw materials and OEM/ODM contract manufacturing services; and (5) INCI-certified exosome ingredients including Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956). The company also develops consumer-facing brands including Karela (plant skincare), MUiKA (hair growth), J-STARMi (high-concentration exosome serum), and iLISSE (sensitive skin). Core technology focuses on freeze-drying preservation and high-purity exosome extraction for applications in beauty, health, and pet care sectors.

Differentiator

Problem solved

Functional benefit

Brands

• Karela: Plant-derived skincare brand featuring natural ingredients for skin health.
• MUiKA
• J-STARMi
• iLISSE

Products and services

• Human Hair Follicle Dermal Papilla Cell Exosomes (人類毛囊真皮乳突細胞外泌體) Exosome raw material derived from human hair follicle dermal papilla cells (HFDPCs) through rigorous culture, purification, and standardized quality manufacturing. INCI certified (INCI ID: 40983) for cosmetic ingredient labeling and scalp/skin product development. Sold to cosmetics brands as a B2B raw material.
• Organic Rice Bran-Derived Vesicles (米糠胞外體) Extracellular vesicles extracted from organic rice bran using standardized separation and nano-level EV technology. INCI certified (INCI ID: 40956) for cosmetic formulations targeting hair volumizing, moisturizing, and skin refining. Sold as a B2B raw material to skincare and haircare brands.
• Mesenchymal Stem Cells (MSC) - Pet Cell Product Mesenchymal stem cells derived from cats and dogs bone marrow, adipose tissue, and umbilical cords. Exhibits high proliferative capacity and multipotent differentiation potential for gene preservation and pet health management applications. Sold as a customized B2B cell product.
• Induced Pluripotent Stem Cells (iPSC) - Pet Cell Product Cells reprogrammed from cats and dogs back to a pluripotent state for gene preservation and biomedical research. Sold as a customized B2B cell product for veterinary and biomedical applications.
• Fibroblast - Pet Cell Product Fibroblast-derived exosomes from cats and dogs, rich in collagen-related factors for skin conditioning and pet health applications. Sold as a customized B2B cell product.
• Neural Stem Cells (NSC) - Pet Cell Product Neural stem cell-derived exosomes with nerve factors for studies of neuronal function and central nervous system health in cats and dogs. Sold as a customized B2B cell product.
• Hair Precursor Cells (HPC) - Pet Cell Product Hair precursor cell exosomes rich in nutritional factors relevant to hair follicle vitality, supporting hair quality and density research in cats and dogs. Sold as a customized B2B cell product.
• Pet Exosome Extraction and Mass Production (寵物外泌體萃取量產) Customized exosome extraction and mass production service from MSC, iPSC, Fibroblast, NSC, HPC, and plant cell sources, available in lyophilized powder (long-term storage) and frozen liquid (high activity) formats. Sold as a B2B service to pet health and veterinary companies.
• Plant Extracellular Vesicles Extraction and Mass Production (植物胞外囊泡萃取量產) High-purity extraction and scalable production of plant-derived extracellular vesicles from functional plant sources, suitable for nutraceuticals, skincare, and haircare products. Available in lyophilized powder and frozen liquid formats with customization options. Sold as a B2B service.
• Exosome Lyophilization Service (外泌體冷凍乾燥服務) Professional fee-for-service lyophilization (freeze-drying) using low-temperature vacuum sublimation (-40°C to -80°C) to preserve exosomes, proteins, natural plant extracts, and cytokines for third-party biotech companies, research institutions, and cosmetics manufacturers. Reduces cold-chain dependency for global distribution.
• Cosmetics/Skincare Raw Materials and OEM/ODM (化妝/保養品原物料及OEM/ODM) One-stop OEM/ODM contract manufacturing service combining supply of high-quality, stable exosome raw materials with end-to-end brand product manufacturing from concept design to finished product. Offers customization for repair, anti-aging, brightening, and moisturizing skincare applications.
• Karela - Plant-Derived Skincare Brand Plant-derived skincare brand featuring natural ingredients developed using Sparkling Sciences' exosome technology for skin health applications. Showcased to B2B partners at trade exhibitions.
• MUiKA - Hair Growth Brand Hair growth brand utilizing high-activity freeze-dried exosome technology for scalp and hair care applications. Showcased to B2B partners at trade exhibitions.
• J-STARMi - High-Concentration Exosome Serum High-concentration exosome serum featuring proprietary freeze-drying technology to preserve exosome activity, positioned as a premium skincare product. Showcased to B2B partners at trade exhibitions.
• iLISSE - Sensitive Skin Brand

Quantifiable outcome

• Exosome freeze-drying technology enables room-temperature shelf stability, reducing cold-chain dependency and transport risk for global distribution
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Tomo Yume Bio-Tech (友夢生醫)coreStrategic or Co-development Partner · 1 September 2025Sparkling Sciences is the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). Tomo Yume Bio-Tech is the parent company and holding entity, with Sparkling Sciences serving as the dedicated R&D and manufacturing arm for exosome ingredients. Dr. Jen Kao founded Tomo Yume Bio-Tech in 2024 and established Sparkling Sciences as its R&D subsidiary in the same year. The two entities exhibit together at industry events, such as the 2026 Taipei Pet Products Expo, presenting combined pet biotechnology innovations.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ExoCoBio: South Korean biotechnology company specializing in exosome-based cosmetic ingredients and stem cell-derived skincare products. Direct competitor targeting the same B2B cosmetics ingredient market with similar INCI-registered exosome offerings.
• Kimera Labs: US biotechnology company specializing in exosome isolation and production for regenerative medicine and skincare applications. Direct competitor with similar exosome manufacturing capabilities targeting cosmetics and therapeutic markets.
• BENEV Company Inc. US-based company producing exosome-based regenerative skincare products and cosmetic ingredients for professional use. Direct competitor offering similar lyophilized exosome raw materials and OEM-style services to skincare brands.
• Rion Aesthetics: US company offering exosome-based regenerative skincare products and professional treatment systems. Comparable as a peer developing exosome-based cosmetic products for both consumer and professional B2B channels.

Emerging players

• Stemmatters: Portuguese biotechnology company developing exosome-based products for regenerative medicine and cosmetics. Emerging peer with partial overlap in exosome manufacturing and skin/hair applications.
• Codi Biobiosciences: Korean biotech firm developing extracellular vesicle and exosome-based ingredients for cosmetic and therapeutic applications. Emerging peer with similar cell-sourced exosome technology targeting skincare brands.
• ExoPro Medical: Biotech company developing exosome-based products for skin regeneration and cosmetic applications. Emerging peer with overlapping R&D focus on plant and animal-derived exosome ingredients for skincare.

Broad incumbents

• Amorepacific Corporation: Major South Korean cosmetics conglomerate with significant in-house biotechnology research including exosome and stem cell programs for skincare. Represents a larger incumbent that competes for the same B2B brand and consumer markets with broader product portfolios.
• Shiseido Company: Major Japanese cosmetics company with extensive biotech research including exosome and regenerative skincare programs. Direct presence in Sparkling Sciences' home market of Japan and Taiwan, competing for premium skincare brand partnerships.

Regional players

• Cellavision: Asian biotech developing cell-based and exosome technologies for skincare and pharmaceutical applications. Regional peer operating in adjacent Asia-Pacific markets with comparable bioactive ingredient offerings.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sparkling Sciences